The efficacy and safety of glucokinase activators for the treatment of type-2 diabetes mellitus: A meta-analysis

BACKGROUND: Glucokinase activators (GKAs) are a novel family of glucose-lowering agents used for the treatment of type-2 diabetes mellitus. Treatment with different GKAs has been shown to reduce blood glucose levels in these patients. We compared the efficacy/safety of GKAs in patients with type-2 d...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Qian, Zhang, Wenjun, Li, Tingting, Yang, Guojun, Zhu, Wei, Chen, Naijun, Jin, Huawei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500571/
https://www.ncbi.nlm.nih.gov/pubmed/34622877
http://dx.doi.org/10.1097/MD.0000000000027476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500571/
https://www.ncbi.nlm.nih.gov/pubmed/34622877
http://dx.doi.org/10.1097/MD.0000000000027476

Ejemplares similares